This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for Xalkori® (crizotinib) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Xalkori (crizotinib)  -  200mg hard capsule - PI for GB
  • Xalkori (crizotinib)  -  250mg hard capsule- PI for GB

Northern Ireland

  • Xalkori (crizotinib) - 200mg and 250mg hard capsule - PI for NI

Xalkori (crizotinib)  -  200mg hard capsule - PI for GB

Xalkori (crizotinib)  -  250mg hard capsule- PI for GB

Xalkori (crizotinib)  - 200mg and  250mg hard capsule - PI for NI

PP-XLK-GBR-1239 October 2021